Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
FOCIS: Advanced Course in Basic & Clinical Immunology
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.
American Academy of Neurology Annual Meeting
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors - Implications for dose-sparing combination therapies.
Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy and first in a new class
Three-Month Test-Retest Reliability of Center of Pressure Motion During Standing Balance in Individuals with Multiple Sclerosis.
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Live Webcast: Assessing the Potential Impact of New and Emerging Disease-Modifying Therapies on the Initial Treatment and Comprehensive Management of Multiple Sclerosis
The endocannabinoid system and multiple sclerosis.
The role of global and regional gray matter volume decrease in multiple sclerosis.
Reassessing the risk of natalizumab-associated PML.
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
BRIEF: Teva files for Copaxone-Laquinimod patent
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis.
ForuMS: A Virtual Journal Club for MS Clinicians
Episode 21 with Dr. Paul Matthews discussing imaging in MS
Development of Guillain-Barré syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
A monoclonal natural human IgM protects axons in the absence of remyelination.

Pages